Journal article
The conditional survival analysis of relapsed DLBCL after autologous transplant: a subgroup analysis of LY.12 and CORAL
Abstract
The conditional survival of patients after frontline therapy for diffuse large B-cell lymphoma (DLBCL) approaches that of the general population once patients have survived disease free for 2 years. We sought to determine the conditional survival of patients among patients with relapsed de novo DLBCL successfully undergoing an autologous stem-cell transplant (ASCT) after first relapse. A total of 478 patients with de novo DLBCL, relapsed after …
Authors
Assouline S; Li S; Gisselbrecht C; Fogarty P; Hay A; van den Neste E; Shepherd LE; Schmitz N; Baetz T; Keating A
Journal
Blood Advances, Vol. 4, No. 9, pp. 2011–2017
Publisher
American Society of Hematology
Publication Date
May 12, 2020
DOI
10.1182/bloodadvances.2020001646
ISSN
2473-9529